Search Results - "Ren, Xiubao"
-
1
Cancer immunology and immunotherapy
Published in Cancer biology & medicine (01-11-2021)Get full text
Journal Article -
2
Immunosuppressive checkpoint Siglec-15: a vital new piece of the cancer immunotherapy jigsaw puzzle
Published in Cancer biology & medicine (01-05-2019)Get full text
Journal Article -
3
Immunotherapy for hepatocellular carcinoma
Published in Drug Discoveries & Therapeutics (01-10-2015)“…Hepatocellular carcinoma (HCC) is the most common type of hepatic malignancies, with poor prognosis. Treatment for HCC are limited, especially for patients…”
Get full text
Journal Article -
4
Novel strategies for cancer immunotherapy: counter-immunoediting therapy
Published in Journal of hematology and oncology (13-04-2023)“…The advent of immunotherapy has made an indelible mark on the field of cancer therapy, especially the application of immune checkpoint inhibitors in clinical…”
Get full text
Journal Article -
5
The role of toll-like receptor 4 in tumor microenvironment
Published in Oncotarget (12-09-2017)“…Tumors are closely related to chronic inflammation, during which there are various changes in inflammatory sites, such as immune cells infiltration,…”
Get full text
Journal Article -
6
New Insights into Tumor-Infiltrating B Lymphocytes in Breast Cancer: Clinical Impacts and Regulatory Mechanisms
Published in Frontiers in immunology (08-03-2018)“…Currently, tumor-infiltrating B lymphocytes have been recognized as a new hallmark of breast cancer (BC). The function seems to be controversial, either with…”
Get full text
Journal Article -
7
The Clinical Significance of SIRT2 in Malignancies: A Tumor Suppressor or an Oncogene?
Published in Frontiers in oncology (08-09-2020)“…Sirtuin 2 (SIRT2) is a member of the sirtuin protein family. It is a Class III histone deacetylase (HDACs) and predominantly localized to the cytosol. SIRT2…”
Get full text
Journal Article -
8
Chemotherapy-Induced Extracellular Vesicle miRNAs Promote Breast Cancer Stemness by Targeting ONECUT2
Published in Cancer research (Chicago, Ill.) (15-07-2019)“…Cancer-secreted, extracellular vesicle (EV)-encapsulated miRNAs enable cancer cells to communicate with each other and with noncancerous cells in tumor…”
Get full text
Journal Article -
9
Breast-cancer-secreted miR-122 reprograms glucose metabolism in premetastatic niche to promote metastasis
Published in Nature cell biology (01-02-2015)“…Reprogrammed glucose metabolism as a result of increased glycolysis and glucose uptake is a hallmark of cancer. Here we show that cancer cells can suppress…”
Get full text
Journal Article -
10
Editorial: Endogenous danger signals in cancer immunology and immunotherapy
Published in Frontiers in immunology (13-06-2024)Get full text
Journal Article -
11
Myeloid-derived suppressor cells regulate the immunosuppressive functions of PD-1−PD-L1+ Bregs through PD-L1/PI3K/AKT/NF-κB axis in breast cancer
Published in Cell death & disease (09-05-2021)“…Myeloid-derived suppressor cells (MDSCs) are a heterogeneous group of myeloid cells that are closely related to tumor immune escape, but the mechanism by which…”
Get full text
Journal Article -
12
Exhausted T cells and epigenetic status
Published in Cancer biology & medicine (15-11-2020)“…Exhausted T cells are a group of dysfunctional T cells, which are present in chronic infections or tumors. The most significant characteristics of exhausted T…”
Get full text
Journal Article -
13
Chromosome Abnormalities: New Insights into Their Clinical Significance in Cancer
Published in Molecular therapy. Oncolytics (26-06-2020)“…Chromosomal abnormalities, consisting of numerical and structural chromosome abnormalities, are a common characteristic of cancer. Numerical chromosome…”
Get full text
Journal Article -
14
High Indoleamine 2,3-Dioxygenase Is Correlated With Microvessel Density and Worse Prognosis in Breast Cancer
Published in Frontiers in immunology (17-04-2018)“…Indoleamine 2,3-dioxygenase (IDO), which catalyzes the breakdown of the essential amino acid tryptophan into kynurenine, is understood to have a key role in…”
Get full text
Journal Article -
15
Long non-coding RNA HOTAIR promotes tumor cell invasion and metastasis by recruiting EZH2 and repressing E-cadherin in oral squamous cell carcinoma
Published in International journal of oncology (01-06-2015)“…HOX transcript antisense RNA (HOTAIR), a long intergenic non-coding RNA (lncRNA), functions as a molecular scaffold to link and target the histone modification…”
Get full text
Journal Article -
16
Fibroblast activation protein: A potential therapeutic target in cancer
Published in Cancer biology & therapy (01-02-2012)“…The concept of targeting antigens selectively expressed on the surface of tumor capillary endothelial cells or in tumor stroma has emerged as a promising…”
Get full text
Journal Article -
17
The role of phosphoglycerate mutase 1 in tumor aerobic glycolysis and its potential therapeutic implications
Published in International journal of cancer (01-11-2014)“…A significant characteristic of cancer cell metabolism is the high level of aerobic glycolysis with high glucose consumption and lactate production…”
Get full text
Journal Article -
18
CCL2 Mediates Cross-talk between Cancer Cells and Stromal Fibroblasts That Regulates Breast Cancer Stem Cells
Published in Cancer research (Chicago, Ill.) (01-06-2012)“…Cancer stem cells (CSC) play critical roles in cancer initiation, progression, and therapeutic refractoriness. Although many studies have focused on the genes…”
Get full text
Journal Article -
19
Expression signature, prognosis value, and immune characteristics of Siglec-15 identified by pan-cancer analysis
Published in Oncoimmunology (01-01-2020)“…Sialic acid-binding immunoglobulin-like lectin 15 (Siglec-15) is considered a novel anti-tumor target comparable to programmed cell death 1 ligand 1(PD-L1)…”
Get full text
Journal Article -
20
Insights into tertiary lymphoid structures in the solid tumor microenvironment: anti-tumor mechanism, functional regulation, and immunotherapeutic strategies
Published in Cancer biology & medicine (01-11-2021)“…Tertiary lymphoid structures (TLSs) are ectopic immune cell aggregations that develop in peripheral tissues in response to a wide range of chronic inflammatory…”
Get full text
Journal Article